Crinetics Pharmaceuticals (CRNX) Profit Metrics
Price: $33.11
Market Cap: $3.08B
Avg Volume: 1.01M
Market Cap: $3.08B
Avg Volume: 1.01M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Profit Metrics Summary (Annual)
According to Crinetics Pharmaceuticals's latest annual financial reports:
- The company has reported a gross profit of 1.04M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 100.00%, with a year-over-year growth of -74.11%.
- Crinetics Pharmaceuticals's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -338.85M. The EBITDA margin stands at -32613.47%, showing a growth of -52.97% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at -338.85M. The operating margin is -32613.47%, with a year-over-year growth of -52.22%.
- The net income, which shows the company's total earnings or profit after all expenses, is -298.41M. The net profit margin is -28720.69%, demonstrating a growth of -39.10% from the previous year.
These metrics provide a comprehensive overview of Crinetics Pharmaceuticals's profitability and operational efficiency over the past year.
Gross Profit
$1.04M
Gross Profit Margin (2023)
100.00%
EBITDA
$-338.85M
EBITDA Margin
-32613.47%
Operating Income (2023)
$-338.85M
Operating Margin
-32613.47%
Net Income
$-298.41M
Net Profit Margin
-28720.69%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
Crinetics Pharmaceuticals Historical Profit Metrics
Crinetics Pharmaceuticals Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $1.04M | -74.11% | $-338.85M | -52.22% | $-298.41M | -39.10% | $-338.85M | -52.97% |
| 2023 | $4.01M | 19.86% | $-222.61M | -32.60% | $-214.53M | -34.12% | $-221.51M | -32.72% |
| 2022 | $3.35M | 1919.57% | $-167.88M | -55.88% | $-159.95M | -49.88% | $-166.90M | -56.30% |
| 2021 | $-184.00K | 99.68% | $-107.70M | -43.69% | $-106.72M | -46.46% | $-106.78M | -47.11% |
| 2020 | $-56.93M | -71258.75% | $-74.95M | -39.24% | $-72.86M | -47.10% | $-72.59M | -47.21% |
| 2019 | $80.00K | 100.36% | $-53.83M | -87.50% | $-49.53M | -82.68% | $-49.31M | -74.61% |
| 2018 | $-22.05M | -206.78% | $-28.71M | -214.56% | $-27.11M | -196.11% | $-28.24M | -213.80% |
| 2017 | $-7.19M | -59.34% | $-9.13M | -51.01% | $-9.16M | -52.13% | $-9.00M | -51.19% |
| 2016 | $-4.51M | 0.00% | $-6.04M | 0.00% | $-6.02M | 0.00% | $-5.95M | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for CRNX.